← Eichor
Study identifier: NCT06514677 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Non-Surgical Treatment of Peri-Implantitis With Ultrasonic Carbon Tip

Condition: Peri-Implantitis · Alveolar Bone Loss  ·  Sponsor: Kutahya Health Sciences University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

As the frequency of dental implants increases, the incidence of complications and peri-implant diseases also increases. Early diagnosis and treatment of the disease is important to prevent consequences up to implant loss. Non-surgical treatment is the recommended treatment in the first stage due to its shorter duration and low morbidity rate. Non-surgical treatment of peri-implantitis provides clinical improvements such as reduced bleeding on probing (20-50%) and, in some cases, reduced pocket depth (≤ 1 mm). This study aims to clinically and radiographically compare two different mechanical treatments in patients with mild and moderate peri-implantitis.

This description comes directly from the study's public registry record.

Talk to the study team

Berceste Guler Ayyildiz, d  ·  +90 (274) 260 00 43  ·  berceste.guler@ksbu.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Kütahya Health Sciences University Faculty of Dentistry, Department of PeriodontologyKütahya, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06514677